Research Analysts’ Downgrades for November 17th (ACRS, AIB, AKBA, AYTU, HMY, IDA, IQ, KR, PEP, PRG)

Research Analysts’ downgrades for Tuesday, November 17th:

Aclaris Therapeutics (NASDAQ:ACRS) was downgraded by analysts at Wedbush from an outperform rating to a neutral rating. They currently have $3.00 target price on the stock, down from their previous target price of $8.00.

AIB Data Centers (NYSEAMERICAN:AIB) was downgraded by analysts at Maxim Group from a buy rating to a hold rating.

Akebia Therapeutics (NASDAQ:AKBA) was downgraded by analysts at Wall Street Zen from a sell rating to a strong sell rating.

Aytu BioPharma (NASDAQ:AYTU) was downgraded by analysts at Maxim Group from a buy rating to a hold rating.

Aytu BioPharma (NASDAQ:AYTU) was downgraded by analysts at Lake Street Capital from a buy rating to a hold rating. They currently have $2.70 price target on the stock.

Harmony Gold Mining (NYSE:HMY) was downgraded by analysts at Wall Street Zen from a buy rating to a hold rating.

IDACORP (NYSE:IDA) was downgraded by analysts at Jefferies Financial Group from a buy rating to a hold rating. They currently have $163.00 price target on the stock, up from their previous price target of $155.00.

iQIYI (NASDAQ:IQ) was downgraded by analysts at New Street Research from a buy rating to a neutral rating.

Kroger (NYSE:KR) was downgraded by analysts at Wall Street Zen from a buy rating to a hold rating.

PepsiCo (NASDAQ:PEP) was downgraded by analysts at Sanford C. Bernstein from a market perform rating to an underperform rating. They currently have $128.00 target price on the stock, down from their previous target price of $131.00.

PROG (NYSE:PRG) was downgraded by analysts at Loop Capital from a buy rating to a hold rating. The firm currently has $40.00 price target on the stock.

Rapid Micro Biosystems (NASDAQ:RPID) was downgraded by analysts at Roth Capital from a buy rating to a neutral rating. The firm currently has $0.75 target price on the stock, down from their previous target price of $3.00.

Shoals Technologies Group (NASDAQ:SHLS) was downgraded by analysts at UBS Group from a buy rating to a neutral rating. They currently have $9.00 target price on the stock, down from their previous target price of $12.00.

Stellantis (NYSE:STLA) was downgraded by analysts at Oddo Bhf from a neutral rating to an underperform rating. The firm currently has $3.30 target price on the stock.

Stanley Black & Decker (NYSE:SWK) was downgraded by analysts at Mizuho from an outperform rating to a neutral rating. The firm currently has $120.00 target price on the stock, up from their previous target price of $105.00.

TIM (NYSE:TIMB) was downgraded by analysts at Bank of America from a buy rating to a neutral rating. Bank of America currently has $21.00 target price on the stock.

Tyson Foods (NYSE:TSN) was downgraded by analysts at JPMorgan Chase & Co. from an overweight rating to a neutral rating. They currently have $65.00 price target on the stock, up from their previous price target of $63.00.

Valmont Industries (NYSE:VMI) was downgraded by analysts at Wall Street Zen from a buy rating to a hold rating.

Receive News & Ratings for Aclaris Therapeutics Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aclaris Therapeutics Inc and related companies with MarketBeat.com's FREE daily email newsletter.